Literature DB >> 2019857

In-vitro comparative activity of fluconazole and other antifungal agents against Blastoschizomyces capitatus.

M Venditti1, B Posteraro, G Morace, P Martino.   

Abstract

Blastoschizomyces capitatus represents an emerging fungal pathogen in acute leukemia patients. The susceptibility to amphotericin B, 5-fluorocytosine, ketoconazole and fluconazole of nine clinical isolates was evaluated. A specific medium (high resolution medium) was used for testing fluconazole. This agent and 5-fluorocytosine were at least four- to eight-fold more active than amphotericin B and ketoconazole against all isolates but one.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2019857     DOI： 10.1080/1120009x.1991.11739056

Source DB:  PubMed          Journal:  J Chemother        ISSN： 1120-009X            Impact factor:   1.714


  8 in total

Review 1.  Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

Review 2.  Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature.

Authors:  Corrado Girmenia; Livio Pagano; Bruno Martino; Domenico D'Antonio; Rosa Fanci; Giorgina Specchia; Lorella Melillo; Massimo Buelli; Giampaolo Pizzarelli; Mario Venditti; Pietro Martino
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

3.  Fatal Trichosporon pullulans breakthrough fungemia in cancer patients: report of three patients who failed on prophylaxis with itraconazole.

Authors:  A Kunová; J Godal; J Sufliarsky; S Spanik; T Kollar; V Krcméry
Journal:  Infection       Date:  1996 May-Jun       Impact factor: 3.553

Review 4.  Geotrichum capitatum septicemia: case report and review of the literature.

Authors:  H Trabelsi; S Néji; L Gargouri; H Sellami; R Guidara; F Cheikhrouhou; H Bellaaj; F Makni; M Elloumi; A Ayadi
Journal:  Mycopathologia       Date:  2015-02-14       Impact factor: 2.574

5.  Report of catheter-associated Trichosporon pullulans break-through fungemia in a cancer patient.

Authors:  A Kunová; D Sorkovská; J Sufliarsky; L Helpienska; V Krcmery
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-08       Impact factor: 3.267

6.  In vitro susceptibility testing of Geotrichum capitatum: comparison of the E-test, disk diffusion, and Sensititre colorimetric methods with the NCCLS M27-A2 broth microdilution reference method.

Authors:  C Girmenia; G Pizzarelli; D D'Antonio; F Cristini; P Martino
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

7.  Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy.

Authors:  Paul Chittick; Elizabeth L Palavecino; Brian Delashmitt; James Evans; James E Peacock
Journal:  Antimicrob Agents Chemother       Date:  2009-09-08       Impact factor: 5.191

8.  Fluconazole treatment of Blastoschizomyces capitatus meningitis in an allogeneic bone marrow recipient.

Authors:  C Girmenia; A Micozzi; M Venditti; G Meloni; A P Iori; S Bastianello; P Martino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-09       Impact factor: 3.267
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.